BRIDGER MANAGEMENT, LLC - Q1 2022 holdings

$610 Million is the total value of BRIDGER MANAGEMENT, LLC's 52 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 45.5% .

 Value Shares↓ Weighting
GDDY SellGODADDY INCcl a$52,869,000
-14.9%
631,653
-13.7%
8.67%
+8.0%
UBER  UBER TECHNOLOGIES INC$36,265,000
-14.9%
1,016,4090.0%5.95%
+7.9%
MS SellMORGAN STANLEY$32,739,000
-19.9%
374,592
-10.0%
5.37%
+1.6%
CZR SellCAESARS ENTERTAINMENT INC NE$32,495,000
-18.7%
420,053
-1.7%
5.33%
+3.1%
CLVT BuyCLARIVATE PLC$30,843,000
-18.0%
1,840,280
+15.1%
5.06%
+4.0%
CNC SellCENTENE CORP DEL$29,601,000
-14.5%
351,600
-16.4%
4.86%
+8.4%
CHTR  CHARTER COMMUNICATIONS INC Ncl a$28,727,000
-16.3%
52,6590.0%4.71%
+6.1%
ALC BuyALCON AG$28,021,000
+17.3%
353,215
+28.8%
4.60%
+48.7%
ROST SellROSS STORES INC$27,877,000
-30.0%
308,168
-11.6%
4.57%
-11.3%
VRSN SellVERISIGN INC$27,210,000
-32.5%
122,314
-22.9%
4.46%
-14.3%
IRTC SellIRHYTHM TECHNOLOGIES INC$24,956,000
-31.4%
158,479
-48.7%
4.09%
-13.0%
SellAIRSCULPT TECHNOLOGIES INC$22,366,000
-22.5%
1,634,941
-2.6%
3.67%
-1.7%
VRTX BuyVERTEX PHARMACEUTICALS INC$21,608,000
+65.7%
82,800
+39.4%
3.54%
+110.1%
LKQ SellLKQ CORP$16,483,000
-30.6%
362,987
-8.2%
2.70%
-12.0%
SKIN BuyTHE BEAUTY HEALTH COMPANY$15,702,000
-7.2%
930,210
+32.8%
2.58%
+17.7%
TEVA  TEVA PHARMACEUTICAL INDS LTDsponsored ads$14,085,000
+17.2%
1,500,0000.0%2.31%
+48.6%
DG  DOLLAR GEN CORP NEW$13,558,000
-5.6%
60,9000.0%2.22%
+19.8%
PSPCU  POST HOLDINGS PARTNERING CORunit 99/99/9999$12,375,000
-3.1%
1,250,0000.0%2.03%
+22.9%
IRWD  IRONWOOD PHARMACEUTICALS INC$11,696,000
+7.9%
929,7140.0%1.92%
+36.8%
POST SellPOST HLDGS INC$10,223,000
-50.3%
147,598
-19.2%
1.68%
-37.0%
AVANU  AVANTI ACQUISITION CORPunit 99/99/9999$9,970,000
-1.3%
1,000,0000.0%1.64%
+25.2%
GLPG NewGALAPAGOS NVspon adr$9,532,000153,700
+100.0%
1.56%
 WILLIAMS ROWLAND ACQUISITION$9,472,000
+1.0%
950,0000.0%1.55%
+28.0%
MSGS NewMADISON SQUARE GRDN SPRT CORcl a$7,533,00042,000
+100.0%
1.24%
CRM NewSALESFORCE COM INC$7,113,00033,500
+100.0%
1.17%
GDS SellGDS HLDGS LTDsponsored ads$5,888,000
-68.4%
150,000
-62.0%
0.97%
-59.9%
CUTR SellCUTERA INC$5,756,000
-21.3%
83,422
-52.9%
0.94%
-0.2%
BuyDERMTECH INC$5,420,000
+51.7%
369,200
+63.3%
0.89%
+92.4%
NewDOCEBO INC$5,365,000103,700
+100.0%
0.88%
HCA SellHCA HEALTHCARE INC$5,164,000
-70.2%
20,606
-69.5%
0.85%
-62.2%
FLME NewFLAME ACQUISITION CORP$4,875,000500,000
+100.0%
0.80%
MSOS BuyADVISORSHARES TRpure us cannabis$4,466,000
-1.1%
214,100
+21.3%
0.73%
+25.3%
NewBELLRING BRANDS INC$4,319,000187,122
+100.0%
0.71%
PRVA NewPRIVIA HEALTH GROUP INC$3,483,000130,300
+100.0%
0.57%
LIVN SellLIVANOVA PLC$3,183,000
-20.7%
38,900
-15.3%
0.52%
+0.6%
TECH SellBIO-TECHNE CORP$2,895,000
-22.2%
6,686
-7.0%
0.48%
-1.2%
QTRX SellQUANTERIX CORP$2,720,000
-63.6%
93,184
-47.1%
0.45%
-53.8%
ABCM BuyABCAM PLCads$2,604,000
+6.5%
142,350
+37.1%
0.43%
+35.1%
MORF NewMORPHIC HLDG INC$2,558,00063,700
+100.0%
0.42%
CF NewCF INDS HLDGS INC$2,513,00024,380
+100.0%
0.41%
NewRXSIGHT INC$2,459,000198,600
+100.0%
0.40%
IMGN NewIMMUNOGEN INC$2,390,000502,000
+100.0%
0.39%
AMZN NewAMAZON COM INC$2,125,000652
+100.0%
0.35%
 SURROZEN INCcl a$2,107,000
-53.3%
700,0010.0%0.35%
-40.7%
NEXI  NEXIMMUNE INC$1,684,000
-8.7%
400,0000.0%0.28%
+16.0%
NAUT  NAUTILUS BIOTECHNOLOGY INC$1,254,000
-16.2%
289,0000.0%0.21%
+6.2%
FB NewMETA PLATFORMS INCcl a$1,055,0004,744
+100.0%
0.17%
GOOGL NewALPHABET INCcap stk cl a$957,000344
+100.0%
0.16%
OLK  OLINK HLDG ABsponsored ads$811,000
-3.0%
45,9250.0%0.13%
+23.1%
MYPSW  PLAYSTUDIOS INC*w exp 06/17/202$119,000
+41.7%
141,1050.0%0.02%
+81.8%
 WILLIAMS ROWLAND ACQUISITION*w exp 12/11/202$124,000
-49.8%
475,0000.0%0.02%
-37.5%
 SURROZEN INC*w exp 08/01/203$117,000
-78.2%
466,6660.0%0.02%
-72.5%
DXCM ExitDEXCOM INC$0-2,677
-100.0%
-0.19%
ATRA ExitATARA BIOTHERAPEUTICS INC$0-616,488
-100.0%
-1.26%
SHC ExitSOTERA HEALTH CO$0-551,626
-100.0%
-1.68%
ExitOLAPLEX HLDGS INC$0-504,400
-100.0%
-1.90%
ETSY ExitETSY INC$0-97,763
-100.0%
-2.77%
NTRA ExitNATERA INC$0-313,320
-100.0%
-3.78%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VERISIGN INC40Q1 20235.2%
TEVA PHARMACEUTICAL INDS LTD40Q3 20237.3%
MORGAN STANLEY35Q3 202311.8%
ALNYLAM PHARMACEUTICALS INC34Q3 20214.9%
POST HLDGS INC33Q4 20226.1%
TG THERAPEUTICS INC33Q3 20213.8%
CHARTER COMMUNICATIONS INC N30Q3 20237.2%
ATARA BIOTHERAPEUTICS INC29Q4 20216.4%
GODADDY INC28Q3 20238.9%
CENTENE CORP DEL28Q3 20226.2%

View BRIDGER MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
BRIDGER MANAGEMENT, LLC Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Surrozen, Inc./DESold outFebruary 14, 202200.0%
Atara Biotherapeutics, Inc.February 16, 20211,524,7601.8%
Dicerna Pharmaceuticals IncFebruary 14, 20201,981,6332.9%
TG THERAPEUTICS, INC.February 14, 20201,907,4921.9%
CHIMERIX INCSold outFebruary 14, 201700.0%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold outFebruary 14, 201700.0%
SeaSpine Holdings CorpSold outFebruary 14, 201700.0%
Trovagene, Inc.Sold outFebruary 14, 201700.0%
ARROWHEAD RESEARCH CORPSold outFebruary 16, 201600.0%
PENNYMAC FINANCIAL SERVICES, INC.Sold outFebruary 16, 201600.0%

View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14

View BRIDGER MANAGEMENT, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (609727000.0 != 609730000.0)

Export BRIDGER MANAGEMENT, LLC's holdings